Patents Assigned to IMMUNE REGULATION LIMITED
  • Publication number: 20210238239
    Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
    Type: Application
    Filed: October 31, 2020
    Publication date: August 5, 2021
    Applicant: IMMUNE REGULATION LIMITED
    Inventors: Valerie Mary Corrigall, Gabriel Stavros Panayi
  • Patent number: 10858409
    Abstract: The present invention provides an isolated or recombinant protein consisting of the amino acid sequence according to SEQ ID NO: 3 or SEQ ID: NO: 4 and its use in the prevention or treatment of an inflammatory condition.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: December 8, 2020
    Assignee: IMMUNE REGULATION LIMITED
    Inventors: Valerie Mary Corrigall, Gabriel Stavros Panayi